Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>BWX Technologies, Inc. reported robust financial performance in the third quarter of 2025, although there are notable elements that both support and challenge its broader financial landscape.</li><li>The company highlighted a 12% rise in organic revenue alongside approximately 20% growth in both adjusted EBITDA and earnings per share, indicating effective operational execution.</li><li>A robust book-to-bill ratio of 2.6 further underscored BWXT's booking strength, driven by significant contracts in national security, particularly in defense fuels and high-purity depleted uranium.</li></ul>

BWX Technologies, Inc. reported robust financial performance in the third quarter of 2025, although there are notable elements that both support and challenge its broader financial landscape.The company highlighted a 12% rise in organic revenue alongside approximately 20% growth in both adjusted EBITDA and earnings per share, indicating effective operational execution.A robust book-to-bill ratio of 2.6 further underscored BWXT's booking strength, driven by significant contracts in national security, particularly in defense fuels and high-purity depleted uranium.

BWX Technologies: Can Its SMR Bet Transform the Future of Clean Energy?

<ul><li>BWX Technologies, Inc., presented robust financial results for the second quarter of 2025, showcasing a strong operational performance that exceeded expectations.</li><li>The key highlights of the quarter include double-digit growth in adjusted EBITDA and earnings per share, alongside substantial free cash flow.</li><li>A significant contributor to the company's promising outlook is the recently closed acquisition of Kinectrics, expanding BWXT's capabilities in the nuclear power and energy infrastructure markets.</li></ul>

BWX Technologies, Inc., presented robust financial results for the second quarter of 2025, showcasing a strong operational performance that exceeded expectations.The key highlights of the quarter include double-digit growth in adjusted EBITDA and earnings per share, alongside substantial free cash flow.A significant contributor to the company's promising outlook is the recently closed acquisition of Kinectrics, expanding BWXT's capabilities in the nuclear power and energy infrastructure markets.

BWX Technologies Expands in Nuclear Innovation—Is This the Next Big Growth Catalyst?

<ul><li>BWX Technologies, Inc. (BWXT) reported its first quarter 2025 financial results, illustrating both robust performance and future growth opportunities.</li><li>The highlights of the quarter included double-digit revenue, EBITDA, and earnings per share growth compared to the previous year.</li><li>This strong performance was attributed to effective execution and an increased pace of work, along with strategic wins in both commercial and government operations.</li></ul>

BWX Technologies, Inc. (BWXT) reported its first quarter 2025 financial results, illustrating both robust performance and future growth opportunities.The highlights of the quarter included double-digit revenue, EBITDA, and earnings per share growth compared to the previous year.This strong performance was attributed to effective execution and an increased pace of work, along with strategic wins in both commercial and government operations.

BWX Technologies: Innovations in Nuclear Medicine & Molybdenum-99 Production Driving Our Optimism!

<ul><li>BWX Technologies, Inc. recorded a strong performance for its fourth quarter and full year 2024, with earnings exceeding initial projections and a significant backlog increase.</li><li>The company achieved records in several financial metrics, including revenue, adjusted EBITDA, adjusted earnings per share, and free cash flow.</li><li>The strategic focus on nuclear technology across various sectors, including national security, clean energy, and medicine, positioned BWX Technologies to harness growing market demand.</li></ul>

BWX Technologies, Inc. recorded a strong performance for its fourth quarter and full year 2024, with earnings exceeding initial projections and a significant backlog increase.The company achieved records in several financial metrics, including revenue, adjusted EBITDA, adjusted earnings per share, and free cash flow.The strategic focus on nuclear technology across various sectors, including national security, clean energy, and medicine, positioned BWX Technologies to harness growing market demand.

BWX Technologies Powers Ahead with Revolutionary Reactor Development Breakthroughs!

<ul><li>BWX Technologies (BWXT) reported robust results in its third-quarter 2024 earnings, showing strong organic revenue growth of 14%.</li><li>This growth, combined with solid operational performance, led to a 19% increase in adjusted EBITDA and a 24% rise in adjusted earnings per share (EPS).</li><li>These results exceeded expectations, prompting the company to raise its 2024 adjusted EPS guidance to around $3.20, the upper limit of its previous range, while maintaining its free cash flow guidance of $225 million to $250 million.</li></ul>

BWX Technologies (BWXT) reported robust results in its third-quarter 2024 earnings, showing strong organic revenue growth of 14%.This growth, combined with solid operational performance, led to a 19% increase in adjusted EBITDA and a 24% rise in adjusted earnings per share (EPS).These results exceeded expectations, prompting the company to raise its 2024 adjusted EPS guidance to around $3.20, the upper limit of its previous range, while maintaining its free cash flow guidance of $225 million to $250 million.

BWX Technologies Inc.: Can Its Microreactors & Small Modular Reactors Market Opportunities Up Their Game? - Major Drivers

United States

BWX Technologies, Inc. supplies nuclear components and fuel to the U.S. government. The Company offers precision manufactured components and services for the commercial nuclear power industry. BWX Technologies also provides technical, management, and site services to support governments in the operation of complex facilities and environmental remediation activities.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Bwx Technologies (BWXT US)

BWX Technologies: Can Its SMR Bet Transform the Future of Clean Energy?

BWX Technologies, Inc. reported robust financial performance in the third quarter of 2025, although there are notable elements that both support...

Baptista Research

BWX Technologies Expands in Nuclear Innovation—Is This the Next Big Growth Catalyst?

BWX Technologies, Inc., presented robust financial results for the second quarter of 2025, showcasing a strong operational performance that...

Baptista Research

BWX Technologies: Innovations in Nuclear Medicine & Molybdenum-99 Production Driving Our Optimism!

BWX Technologies, Inc. (BWXT) reported its first quarter 2025 financial results, illustrating both robust performance and future growth...

Baptista Research

BWX Technologies Powers Ahead with Revolutionary Reactor Development Breakthroughs!

BWX Technologies, Inc. recorded a strong performance for its fourth quarter and full year 2024, with earnings exceeding initial projections and a...

Baptista Research

BWX Technologies Inc.: Can Its Microreactors & Small Modular Reactors Market Opportunities Up Their Game? - Major Drivers

BWX Technologies (BWXT) reported robust results in its third-quarter 2024 earnings, showing strong organic revenue growth of 14%. This growth,...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)